Insight Pharmaceuticals has issued a voluntary recall of one lot of Nostrilla Nasal Decongestant nasal spray as it has the potential to be contaminated with bacteria Burkholderia cepacia.
Subscribe to our email newsletter
Internal investigations revealed the presence of a microbial contaminant that exceeds the product specifications which may subsequently result in a subpar product.
The product bearing the UPC Code, 6373673005, was distributed in the US through retail outlets and pharmacies.
Burkholderia cepacia can cause serious infection in individuals with a weak immune system or chronic lung condition.
The company, however, said that no illnesses have been reported.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.